Your plate was full in 2017 managing Affordable Care Act patients, the False Claims Act, physician employment, cyber-security, shared savings programs, insurer negotiations, sequester cuts and mandatory reporting to Medicare. What new challenges will 2018 bring?
Join Paul Keckley, an industry expert, to learn what to anticipate in 2018 so you can plan for inevitable changes in health reform. Get the understanding you need to begin to answer these questions: “What future state should your organization pursue? What should you do tomorrow?”
Participants will discover:
- What’s in store for Federal and State reimbursement changes?
- What are the biggest threats to health system profit margins?
- How might you use technology to stay ahead of the curve?
Paul Keckley, PhD
Paul Keckley is Managing Editor of The Keckley Report, a healthcare researcher and widely known industry expert. In addition to The Keckley Report, he authors, a monthly column for Health and Hospital Networks and has published three books and 250 articles. During the period preceding the passage of the Affordable Care Act, he facilitated sessions between White House Office of Health Reform sessions and major health industry trade groups as private sector input was sought in the legislation.
He serves on the board of Healthways Inc. as an Advisor to Western Governors University and the Lipscomb University College of Pharmacy. He is also a member of the Health Executive Network.
He served as Managing Director of the Navigant Center for Healthcare Research and Policy Analysis (2014-2015), Executive Director of the Deloitte Center for Health Solutions (2006-2013), executive administration at Vanderbilt University Medical Center (1998-2006), Chief Executive Officer of PhyCor Management Corporation-the IPA Subsidiary of PhyCor Inc. (1994-1998) and Managing Partner of The Keckley Group, a health care research and policy analysis firm (1974-1994). He served as Independent Chairman of Interdent, a California dental practice management company (1992-1996) and as an Adjunct Professor in the Schools of Medicine, Business and Health Policy at Georgetown University and Vanderbilt University.
He completed his B.A.at Lipscomb University, MA and PhD degrees from Ohio State University, and a fellowship in economic policy at Oxford University